Åsa Tivesten1, Liesbeth Vandenput2, Daniel Carlzon2, Maria Nilsson2, Magnus K Karlsson3, Östen Ljunggren4, Elizabeth Barrett-Connor5, Dan Mellström2, Claes Ohlsson2. 1. Wallenberg Laboratory for Cardiovascular and Metabolic Research, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden. Electronic address: asa.tivesten@medic.gu.se. 2. Centre for Bone and Arthritis Research, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden. 3. Department of Clinical Sciences and Orthopaedics, Lund University, Malmö, Sweden. 4. Department of Medical Sciences, University of Uppsala, Uppsala, Sweden. 5. Department of Family and Preventive Medicine, School of Medicine, University of California San Diego, La Jolla, California.
Abstract
BACKGROUND: The adrenal sex hormone dehydroepiandrosterone (DHEA), which is present in serum mainly as the sulfate DHEA-S, is the most abundant steroid hormone in human blood. Its levels decline dramatically with age. Despite the great amount of literature on vascular and metabolic actions of DHEA/-S, evidence for an association between DHEA/-S levels and cardiovascular events is contradictory. OBJECTIVES: This study tested the hypothesis that serum DHEA and DHEA-S are predictors of major coronary heart disease (CHD) and/or cerebrovascular disease (CBD) events in a large cohort of elderly men. METHODS: We used gas and liquid chromatography-mass spectrometry to analyze baseline levels of DHEA and DHEA-S in the prospective population-based Osteoporotic Fractures in Men study in Sweden (2,416 men, ages 69 to 81 years). Complete cardiovascular clinical outcomes were available from national Swedish registers. RESULTS: During the 5-year follow-up, 302 participants experienced a CHD event, and 225 had a CBD event. Both DHEA and DHEA-S levels were inversely associated with the age-adjusted risk of a CHD event; the hazard ratios and 95% confidence intervals per SD increase were 0.82 (0.73 to 0.93) and 0.86 (0.77 to 0.97), respectively. In contrast, DHEA/-S showed no statistically significant association with the risk of CBD events. The association between DHEA and CHD risk remained significant after adjustment for traditional cardiovascular risk factors, serum total testosterone and estradiol, C-reactive protein, and renal function, and remained unchanged after exclusion of the first 2.6 years of follow-up to reduce reverse causality. CONCLUSIONS: Low serum levels of DHEA and its sulfate predict an increased risk of CHD, but not CBD, events in elderly men.
BACKGROUND: The adrenal sex hormone dehydroepiandrosterone (DHEA), which is present in serum mainly as the sulfateDHEA-S, is the most abundant steroid hormone in human blood. Its levels decline dramatically with age. Despite the great amount of literature on vascular and metabolic actions of DHEA/-S, evidence for an association between DHEA/-S levels and cardiovascular events is contradictory. OBJECTIVES: This study tested the hypothesis that serum DHEA and DHEA-S are predictors of major coronary heart disease (CHD) and/or cerebrovascular disease (CBD) events in a large cohort of elderly men. METHODS: We used gas and liquid chromatography-mass spectrometry to analyze baseline levels of DHEA and DHEA-S in the prospective population-based Osteoporotic Fractures in Men study in Sweden (2,416 men, ages 69 to 81 years). Complete cardiovascular clinical outcomes were available from national Swedish registers. RESULTS: During the 5-year follow-up, 302 participants experienced a CHD event, and 225 had a CBD event. Both DHEA and DHEA-S levels were inversely associated with the age-adjusted risk of a CHD event; the hazard ratios and 95% confidence intervals per SD increase were 0.82 (0.73 to 0.93) and 0.86 (0.77 to 0.97), respectively. In contrast, DHEA/-S showed no statistically significant association with the risk of CBD events. The association between DHEA and CHD risk remained significant after adjustment for traditional cardiovascular risk factors, serum total testosterone and estradiol, C-reactive protein, and renal function, and remained unchanged after exclusion of the first 2.6 years of follow-up to reduce reverse causality. CONCLUSIONS: Low serum levels of DHEA and its sulfate predict an increased risk of CHD, but not CBD, events in elderly men.
Authors: Andrey I Egorov; Shannon M Griffin; Reagan R Converse; Jennifer N Styles; Elizabeth A Sams; Anthony Wilson; Laura E Jackson; Timothy J Wade Journal: Environ Res Date: 2017-07-11 Impact factor: 6.498
Authors: Kevin N Keane; Peter M Hinchliffe; Navid Namdar; Jason L Conceicao; Philip Newsholme; John L Yovich Journal: Drug Des Devel Ther Date: 2015-10-09 Impact factor: 4.162
Authors: Xiaoming Jia; Caroline Sun; Olive Tang; Ivan Gorlov; Vijay Nambi; Salim S Virani; Dennis T Villareal; George E Taffet; Bing Yu; Jan Bressler; Eric Boerwinkle; B Gwen Windham; James A de Lemos; Kunihiro Matsushita; Elizabeth Selvin; Erin D Michos; Ron C Hoogeveen; Christie M Ballantyne Journal: J Clin Endocrinol Metab Date: 2020-12-01 Impact factor: 5.958